<Table 1>
 <caption text="

   hiPSC based models of RP and associated characteristic phenotypes.
  
">
 </caption>
 <row row="0">
  <cell col="0" row="0" text="Disease">
  </cell>
  <cell col="1" row="0" text="Mutation">
  </cell>
  <cell col="2" row="0" text="Cell type">
  </cell>
  <cell col="3" row="0" text="Phenotype">
  </cell>
  <cell col="4" row="0" text="Reference">
  </cell>
 </row>
 <row row="1">
  <cell col="0" row="1" text="XLRP">
  </cell>
  <cell col="1" row="1" text="RPGR">
  </cell>
  <cell col="2" row="1" text="3D retinal organoids hiPSC-RPE">
  </cell>
  <cell col="3" row="1" text="Mutations perturb RPGR/gelsolin interaction, compromising gelsolin activation (gelsolin controls actin disassembly in connecting cilium, thereby facilitating rhodopsin transport to POS). Mutations affect cilia length and PR number.">
  </cell>
  <cell col="4" row="1" text="(
     
      Megaw et al., 2017
     
     )
     
     (
     
      Deng et al., 2018
     
     )">
  </cell>
 </row>
 <row row="2">
  <cell col="0" row="2" text="XLRP">
  </cell>
  <cell col="1" row="2" text="RP2">
  </cell>
  <cell col="2" row="2" text="hiPSC-RPE">
  </cell>
  <cell col="3" row="2" text="Complete lack of RP2 protein. IFT20 localization, Golgi cohesion and Gb1 trafficking altered.">
  </cell>
  <cell col="4" row="2" text="(
     
      Schwarz et al., 2015
     
     )">
  </cell>
 </row>
 <row row="3">
  <cell col="0" row="3" text="XLRP">
  </cell>
  <cell col="1" row="3" text="RP2">
  </cell>
  <cell col="2" row="3" text="3D retinal organoids">
  </cell>
  <cell col="3" row="3" text="Complete lack of RP2 protein. Reduced levels of Kif7 at cilia tips (involved in stabilizing cilia tips).">
  </cell>
  <cell col="4" row="3" text="(
     
      Schwarz et al., 2017
     
     )">
  </cell>
 </row>
 <row row="4">
  <cell col="0" row="4" text="RP">
  </cell>
  <cell col="1" row="4" text="RP1">
  </cell>
  <cell col="2" row="4" text="Rod photoreceptors">
  </cell>
  <cell col="3" row="4" text="Decreased number of patient-derived rods
     
      in vitro
     
     .">
  </cell>
  <cell col="4" row="4" text="(
     
      Jin et al., 2011
     
     )">
  </cell>
 </row>
 <row row="5">
  <cell col="0" row="5" text="RP">
  </cell>
  <cell col="1" row="5" text="RP9">
  </cell>
  <cell col="2" row="5" text="Rod photoreceptors">
  </cell>
  <cell col="3" row="5" text="Decreased number of patient-derived rods
     
      in vitro
     
     . Markers for oxidation or endoplasmic reticulum stress. Oxidation is involved in PR degeneration.">
  </cell>
  <cell col="4" row="5" text="(
     
      Jin et al., 2011
     
     )">
  </cell>
 </row>
 <row row="6">
  <cell col="0" row="6" text="RP">
  </cell>
  <cell col="1" row="6" text="PRPH2">
  </cell>
  <cell col="2" row="6" text="Rod photoreceptors">
  </cell>
  <cell col="3" row="6" text="Decreased number of patient-derived rods
     
      in vitro
     
     .">
  </cell>
  <cell col="4" row="6" text="(
     
      Jin et al., 2011
     
     )">
  </cell>
 </row>
 <row row="7">
  <cell col="0" row="7" text="RP">
  </cell>
  <cell col="1" row="7" text="RHO">
  </cell>
  <cell col="2" row="7" text="Rod photoreceptors hiPSC-RPE">
  </cell>
  <cell col="3" row="7" text="Decreased number of patient-derived rods
     
      in vitro
     
     . Markers for oxidation or endoplasmic reticulum stress. Mislocalization of RHO in cytoplasm.">
  </cell>
  <cell col="4" row="7" text="(
     
      Jin et al., 2011
     
     )
     
     (
     
      Jin et al., 2012
     
     )
     
     (
     
      Yoshida et al., 2014
     
     )">
  </cell>
 </row>
 <row row="8">
  <cell col="0" row="8" text="RP">
  </cell>
  <cell col="1" row="8" text="MAK">
  </cell>
  <cell col="2" row="8" text="Retinal progenitor cells">
  </cell>
  <cell col="3" row="8" text="MAK is expressed in the inner segments, cell bodies, and axons of PRs. Loss of retina-specific isoform in mutated cells.">
  </cell>
  <cell col="4" row="8" text="(
     
      Tucker et al., 2011
     
     )">
  </cell>
 </row>
 <row row="9">
  <cell col="0" row="9" text="RP">
  </cell>
  <cell col="1" row="9" text="USH2A">
  </cell>
  <cell col="2" row="9" text="3D retinal organoids hiPSC-RPE">
  </cell>
  <cell col="3" row="9" text="Upregulation of GRP78 and GRP94. Protein misfolding and ER stress. Organoids: Morphological defects, reduced laminin, defect in retinal progenitor cell development, layer formation
     
     RPE: abnormal morphology, lack of pigment foci, and reduced expression of RPE markers">
  </cell>
  <cell col="4" row="9" text="(
     
      Tucker et al., 2013
     
     )
     
     (
     
      Guo et al., 2019
     
     )">
  </cell>
 </row>
 <row row="10">
  <cell col="0" row="10" text="RP">
  </cell>
  <cell col="1" row="10" text="TRNT1">
  </cell>
  <cell col="2" row="10" text="3D retinal organoids">
  </cell>
  <cell col="3" row="10" text="Autophagy defect. Accumulation of LC3-II. Elevated level of oxydative stress.">
  </cell>
  <cell col="4" row="10" text="(
     
      Sharma et al., 2017
     
     )">
  </cell>
 </row>
 <row row="11">
  <cell col="0" row="11" text="RP">
  </cell>
  <cell col="1" row="11" text="MFRP">
  </cell>
  <cell col="2" row="11" text="hiPSC-RPE">
  </cell>
  <cell col="3" row="11" text="Disorganized actin, loss of RPE cellular morphology and apical microvilli.">
  </cell>
  <cell col="4" row="11" text="(
     
      Li et al., 2014
     
     )">
  </cell>
 </row>
 <row row="12">
  <cell col="0" row="12" text="RP">
  </cell>
  <cell col="1" row="12" text="MERTK">
  </cell>
  <cell col="2" row="12" text="hiPSC-RPE">
  </cell>
  <cell col="3" row="12" text="Phagocytosis defects.">
  </cell>
  <cell col="4" row="12" text="(
     
      Ramsden et al., 2017
     
     )">
  </cell>
 </row>
 <row row="13">
  <cell col="0" row="13" text="RP">
  </cell>
  <cell col="1" row="13" text="PRPF31">
  </cell>
  <cell col="2" row="13" text="3D retinal organoids and hiPSC-RPE">
  </cell>
  <cell col="3" row="13" text="RPE: disrupted epithelium (polarity, TER) Phagocytosis and cilia defects
     
     PR: cilia defects, progressive degeneration and cellular stress
     
     RPE defects restored by AAV-PRPF31 gene augmentation">
  </cell>
  <cell col="4" row="13" text="(
     
      Buskin et al., 2018
     
     )
     
     (
     
      Brydon et al., 2019
     
     )">
  </cell>
 </row>
 <row row="14">
  <cell col="0" row="14" text="RP">
  </cell>
  <cell col="1" row="14" text="PRPF8">
  </cell>
  <cell col="2" row="14" text="hiPSC-RPE">
  </cell>
  <cell col="3" row="14" text="Near normal phenotype, no difference regarding phagocytosis">
  </cell>
  <cell col="4" row="14" text="(
     
      Foltz et al., 2018
     
     )">
  </cell>
 </row>
 <row row="15">
  <cell col="0" row="15" text="RP">
  </cell>
  <cell col="1" row="15" text="NRL">
  </cell>
  <cell col="2" row="15" text="3D retinal organoids">
  </cell>
  <cell col="3" row="15" text="Retinal organoids with S-opsin dominant PR population">
  </cell>
  <cell col="4" row="15" text="(
     
      Kallman et al., 2020
     
     )">
  </cell>
 </row>
 <row row="16">
  <cell col="0" row="16" text="Late onset RP">
  </cell>
  <cell col="1" row="16" text="PDE6B">
  </cell>
  <cell col="2" row="16" text="3D retinal organoids">
  </cell>
  <cell col="3" row="16" text="At D230 modified expression of genes regulating cGMP hydrolysis leading to elevated cGMP levels in patient cells.">
  </cell>
  <cell col="4" row="16" text="(
     
      Gao et al., 2020
     
     )">
  </cell>
 </row>
 <statements>
  <statement id="0" text="There are 12 Disease RP in the table." type="">
  </statement>
 </statements>
</Table 1>